Govt Job for Project Associate at Institute of Microbial Technology

Established in 1984, the Institute of Microbial Technology is one among the chain of 37 national laboratories, 6 units and 39 outreach centres of the Council of Scientific and Industrial Research.

Set-up to be a fore-runner in the niche domain of microbial biotechnology, the Institute in its initial years functioned from a start-up laboratory that provided a truly world-class R&D ambience in an area of over 10,000 sq. ft. to its researchers.

In September, 1989, upon completion of the permanent campus, the Institute shifted to occupy an area of about 47 acres, of which the labs covered 22 acres and the residential campus 25 acres.

Post : Project Associate-II =01

Project titled : “Pre-clinical studies and process development for production of tridecaptin M, an antibiotic against colistin resistant Gram negative bacterial infections”

Project Code : MLP-038

Essential Qualification : 1st class in M.Sc. / M.Pharm / M.Tech. in Medicinal Chemistry / Orgainc Chemistry / Pharmaceutical Chemistry with 2 years of experience in synthesis of antibiotics, small molecules, peptides, etc.

Upper Age limit (years) :35

Monthly Emoluments :
(i) Rs. 35,000/- +HRA to Scholars who are selected through a (a) National Eligibility Tests – CSIR-UGC NET including lectureship or GATE or (b) A selection process through National level examinations conducted by Central Government Departments and their agencies and Institutions.
(ii) Rs. 28,000/- +HRA for others who do not fall under (i) above.

ROLLING ADVT. NO. 07-03

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert